A 100% online Postgraduate certificate, flexible and compatible with your professional responsibilities of medical"

Since the 1990s, countries around the world have strengthened their policies to optimize the use of resources, especially with regard to containing health spending. Achieve these goals, they have incorporated strict measures to the recognition and payment of new drugs, their marketing, effectiveness, safety or the requirement for Good Practice certificates.

This regulation has an impact on the economic evaluation of health and the prices of technology management. In this scenario, the Market Access area of a pharmaceutical company has become transcendental given its development of multidisciplinary strategies that allow it to capitalize on the opportunity to enter a particular market with a specific product. Due to its relevance, TECH has created this Postgraduate Certificate, which offers medical professionals the most relevant and recent information in this field, with which you will be able to keep abreast of developments in the operation of the departments of pricing, health economics and market access.

A program that also allows you to delve into the path that a medicine takes after years of development and research, from the different stages to its approval. In addition, this qualification will lead the specialist to be up to date with the authorization processes for marketing (value dossier, estimates of units sold, etc.) and the search for agreements with institutional organizations to its financing.
In this way, in order to achieve the objectives of updating knowledge Market access, Health economics  outcomes research, the professional has innovative teaching material that they will have access to at any time of the day, from an electronic device with an internet connection. In addition, thanks to the Relearning method, the professionals will be able to progress through the in a more natural and progressive way, even reducing the long hours of study.

The professional has before him an excellent opportunity to be up to date in this field, through a 100% online university program, without classes with fixed schedules and compatible with the most demanding responsibilities. 

A program that will give you the keys currently used to overcome the most frequent barriers in financing a drug"

This Postgraduate certificate in Market Access, Health Economics and Outcomes Research contains the most complete and up-to-date scientific program on the market. The most important features of the include:

• The development of practical cases presented by medical experts and in the Pharmaceutical Industry
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connectio

Un temario con un enfoque eminentemente práctico, que te pondrá al día sobre el funcionamiento del departamento de Health economics”    

The program’s teaching staff includes professionals from the sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive education programmed to learn in real situations.

The design of this program focuses on Problem-Based Learning, by means of which the professional must try to solve the different professional practice situations that are presented throughout the academic course. For this purpose, the student will be assisted by an innovative interactive video system created by renowned experts.

You will be able to reduce long hours of study thanks to the Relearning system used by TECH in its programs"

This qualification will allow you to be up to date on formulas to increase market access for new therapeutic options"

In order to create the content of this Postgraduate certificate, this academic institution has a teaching team made up of great professionals in Market Access, Health Economics and Outcomes Research access in the industry. Their well-versed knowledge in this area is reflected in a syllabus, which will lead the specialist to be aware of the main developments in this area. In order to do this, it will also have innovative pedagogical tools, in which TECH has used the latest technology applied to academic teaching.

A program that brings you closer to pharmacoeconomics and the economic evaluation of medicines in a practical way"

Module 1. Market Access, Health Economics and Outcomes Research  

1.1. Introduction to Pharmacoeconomics and Economic Evaluation of Drugs
1.1.1. Basic Concepts
1.1.2. What and why are they used in health decision making?
1.1.3. Opportunity Cost
1.1.4. Consumption of health and non-health resources in studies Pharmacoeconomics (types of costs)
1.1.5. Measurement and estimation of health outcomes (Outcomes)
1.1.6. QALY: concept and methods for its calculation

1.2. Types of complete pharmacoeconomic analyzes most used in Economic Evaluation of Medicines

1.2.1. Cost Minimization Analysis
1.2.2. Cost-effectiveness and cost-utility analysis
1.2.3. Cost-Benefit Analysis
1.2.4. Concept of incremental cost per additional unit of health benefit
1.2.5. Interpretation of the results of economic evaluations and decision rules

1.3. Types of partial pharmacoeconomic analyzes

1.3.1. Cost of illness and studies of costs and consequences
1.3.2. Budget Impact Analysis: what it is, how it is done and what it is used for in making decisions about the price and financing of medicines
1.3.3. Other analyzes to help decision making NNT, MCDA

1.4. Current importance of measuring Health Outcomes

1.4.1. Patient-Reported Health Outcomes PROs and PREs in the Context of Clinical Research
1.4.2. Concept, definition and introduction to measurement with health scales
1.4.3. What can be measured and with what instruments
1.4.4. The EQ-5D SF-36 Questionnaire

1.5. Critical review of economic evaluations published in the literature

1.5.1. Application of existing guide lists
1.5.2. Review of international guides and recommendations for designing and carrying out economic evaluations
1.5.3. Systematic reviews and meta-analyses of published economic evaluations

1.6. Market Access

1.6.1. Environmental. Health Systems Bismark Model and Beveridge Model
1.6.2. Equity/access
1.6.3. Challenges of Health Systems

1.7. Arrival of the medication to the patient

1.7.1. Price negotiation and financing process
1.7.2. Most frequent barriers in financing/pricing of the drug
1.7.3. Price erosion over the life of the drug

1.8. What is market access?

1.8.1. Introduction
1.8.2. How to create an access strategy
1.8.3. Value proposition and strategic market access dossier of a new medicine
1.8.4. Definition and implementation of the access plan for a new therapeutic option

1.9. Different medicine financing models

1.9.1. Financial models (price-volume agreements, spending ceiling, etc.)
1.9.2. Models based on clinical outcomes (risk-sharing programs, etc.)
1.9.3. Schemes of Patient Access-Up
1.9.4. Other formulas to increase market access for new therapeutic options

1.10. HTA Assessment (Health Technology Assessment)

1.10.1. Different methodologies in different countries
1.10.2. Basic standards that an HTA regulation must have
1.10.3. Current Situation and Future Development

A top-level academic option that will take you into the latest developments in the price and financing negotiation processes"